If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nanopore Technologies Regulatory News (ONT)

Share Price Information for Oxford Nanopore Technologies (ONT)

Share Price is delayed by 15 minutes
Get Live Data
120.10    0.00 (0.00%)
Bid:
0.00
Ask:
155.00
Spread: 34.30 (28.418%)
Market Cap: £1.17b
ONT Live PriceLast checked at - London Stock Exchange

Intraday Oxford Nanopore Technologies Share Chart

Duncan Tatton-Brown appointed as Non-Exec Chair

30 Jun 2022 07:15

RNS Number : 7265Q
Oxford Nanopore Technologies plc
30 June 2022
 

30 June 2022

Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Group")

Duncan Tatton-Brown appointed as Non-Executive Chair

Oxford Nanopore Technologies plc, the company behind a new generation of molecular sensing technology based on nanopores, is pleased to announce that Duncan Tatton-Brown will be joining the Group as Non-Executive Chair with effect from 1 August 2022. Duncan will succeed Peter Allen, who will retire from the Board on 31 July 2022.

Duncan brings extensive, relevant experience as an executive and Non-Executive Director of FTSE companies, growth and founder-led technology businesses, and, in particular, where UK-born businesses have grown to have a strong international commercial presence. He has had a distinguished career across a wide range of innovative businesses in the technology, retail and media sectors, including serving as Chief Financial Officer of Ocado Group plc from 2012 to 2020, during which time the business expanded from being a pure-play online grocer to a leading UK technology business serving clients around the world, with revenue growing 3.5 times and technology headcount growing 10-fold. He remains a Senior Advisor to Ocado and currently also serves on the Boards of Cazoo and Trainline.

Duncan holds a master's degree in Engineering from King's College, Cambridge.

Wendy Becker, Senior Independent Director at Oxford Nanopore, said: "We are extremely pleased to have appointed Duncan as the next Chair of Oxford Nanopore. Duncan's impressive track-record of working with FTSE companies that have grown internationally, and extensive board experience, means he is ideally placed to lead the Board as we continue to innovate and grow. On behalf of the Board, I would like to thank Peter for his enormous contribution to Oxford Nanopore and wish him all the best."

Duncan Tatton-Brown, incoming Chair, commented: "I am delighted to be joining Oxford Nanopore at such an exciting time in the company's journey. The company has already achieved a huge amount, and yet the company is in the foothills of its growth journey. The future opportunities for its sensing technology are immense, from the current scientific research community to future uses across health, agriculture, food or environmental applications. This potential is underpinned by its highly innovative and differentiated technology, fantastic team, strong business model and growing customer base. I look forward to working with the Board and the executive team to ensure the ongoing and long-term success of Oxford Nanopore."

Gordon Sanghera, Chief Executive Officer of Oxford Nanopore, said: "Duncan brings substantial board experience of supporting high-tech growth technology companies, critical to our long-term ambition of enabling the analysis of anything, by anyone, anywhere. I would like to thank Peter for his support and guidance over the years and very much look forward to working with Duncan as we enter the next phase of growth."

This announcement is made pursuant to Listing Rule 9.6.11R. There are no other details required to be disclosed under Listing Rule 9.6.13R.

 

[ENDS]

 

For further information, please contact:

Oxford Nanopore Technologies plc

Investors: ir@nanoporetech.com

Media: media@nanoporetech.com

Tulchan Communications LLP

Tom Murray, Olivia Peters, Lisa Jarrett-Kerr

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@tulchangroup.com

This announcement contains inside information for the purposes of the UK version of the market abuse regulation (EU no. 596/2014), which forms part of English law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for arranging the release of this announcement on behalf of the Company is Hannah Coote, Company Secretary of Oxford Nanopore Technologies plc.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGFVVGZGZZG
Date   Source Headline
1st Jul 20264:00 pmRNSIssue of Equity and Total Voting Rights
30th Jun 20267:00 amRNSChanges to Director Roles and Responsibilities
12th Jun 20263:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th Jun 20262:30 pmRNSResult of AGM
1st Jun 20264:00 pmRNSIssue of Equity and Total Voting Rights
21st May 20267:01 amRNSLondon Calling Technology Update
21st May 20267:00 amRNSOxford Nanopore strengthens executive team
13th May 20263:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th May 20267:00 amRNSDirector/PDMR Shareholding
1st May 20263:00 pmRNSIssue of Equity and Total Voting Rights
1st May 20267:00 amRNSPublication of Annual Report and Notice of AGM
15th Apr 20265:30 pmRNSDirector/PDMR Shareholding - LTIP and DBP awards
14th Apr 20264:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
13th Apr 20263:00 pmRNSDirector/PDMR Shareholding - LTIP and DBP awards
1st Apr 20263:00 pmRNSIssue of Equity and Total Voting Rights
26th Mar 20263:00 pmRNSBlock Admission Application
4th Mar 20267:00 amRNS-RUpcoming Investor Events and Conferences
3rd Mar 20264:00 pmRNSGrant of LTIP awards; Director/PDMR Notification
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20264:00 pmRNSIssue of Equity and Total Voting Rights
2nd Mar 20267:00 amRNSAnnual results for the year ended 31 December 2025
27th Feb 20263:00 pmRNSUpdate on legal action against MGI Australia
27th Feb 20261:30 pmRNSDirector Declaration - John O'Higgins
12th Feb 20264:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
2nd Feb 20263:00 pmRNSIssue of Equity and Total Voting Rights
14th Jan 20264:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
7th Jan 20267:00 amRNS-RUpcoming Investor Events and Conferences
2nd Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
12th Dec 20253:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
8th Dec 20259:00 amRNSAGM Post-Meeting Shareholder Engagement Update
8th Dec 20257:00 amRNSAppointment of Francis Van Parys as CEO
1st Dec 20254:00 pmRNSIssue of Equity and Total Voting Rights
27th Nov 20257:00 amRNS-RUpcoming investor conferences
12th Nov 20254:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
7th Nov 20259:00 amRNSONT postpones investor event; reaffirms guidance
3rd Nov 20253:00 pmRNSIssue of Equity and Total Voting Rights
16th Oct 20257:00 amRNS-RUpcoming Investor Conferences and Events
14th Oct 20254:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
6th Oct 20255:30 pmRNSBlock listing Interim Review
1st Oct 20254:00 pmRNSIssue of Equity and Total Voting Rights
12th Sep 20254:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
2nd Sep 20257:00 amRNSInterim results for the 6 months ended 30 June 25
1st Sep 20255:00 pmRNSIssue of Equity and Total Voting Rights
13th Aug 20254:00 pmRNSShare Incentive Plan - Director/PDMR Notification
11th Aug 20257:00 amRNSChief Executive Officer Succession
8th Aug 20257:00 amRNSResult of Audit Tender
6th Aug 20257:00 amRNSCommencement of legal action against MGI Australia
1st Aug 20254:30 pmRNSIssue of Equity and Total Voting Rights
29th Jul 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.